Rationale
Mutations of TBX5 cause Holt–Oram syndrome (HOS) in humans, a
disease characterized by atrial or occasionally ventricular septal defects
in the heart and skeletal abnormalities of the upper extremity. Previous
studies have demonstrated that Tbx5 regulates Osr1
expression in the second heart field (SHF) of E9.5 mouse embryos. However,
it is unknown whether and how Tbx5 and Osr1 interact in atrial
septation.
Objective
To determine if and how Tbx5 and Osr1 interact in the posterior SHF
for cardiac septation.
Methods and Results
In the present study, genetic inducible fate mapping showed that
Osr1-expressing cells contribute to atrial septum
progenitors between E8.0 and E11.0. Osr1 expression in the
pSHF was dependent on the level of Tbx5 at E8.5 and E9.5
but not E10.5, suggesting that the embryo stage before E10.5 is critical for
Tbx5 interacting with Osr1 in atrial septation. Significantly more
atrioventricular septal defects (AVSDs) were observed in embryos with
compound haploinsufficiency for Tbx5 and
Osr1. Conditional compound haploinsufficiency for
Tbx5 and Osr1 resulted in a
significant cell proliferation defect in the SHF, which was associated with
fewer cells in the G2 and M phases and a decreased level of
Cdk6 expression. Remarkably, genetically targeted
disruption of Pten expression in atrial septum progenitors
rescued AVSDs caused by Tbx5 and Osr1
compound haploinsufficiency. There was a significant decrease in
Smo expression, which is a Hedgehog (Hh) signaling
pathway modulator, in the pSHF of Osr1 knockout embryos at
E9.5, implying a role for Osr1 in regulating Hh signaling.
Conclusions
Tbx5 and Osr1 interact to regulate posterior SHF cell cycle
progression for cardiac septation.